Daniel Gibbs is a retired general neurologist with mild Alzheimer's dementia. He has written previously about his experiences as seen from two points of view, doctor and patient, in A Tattoo on my Brain: A Neurologist's Personal Battle against Alzheimer's Disease, Cambridge University Press, 2021 and 2023 (revised edition).

'The book combines professional expertise with personal experience, offering unique and empathetic insights. The writing is clear and accessible, making complex medical concepts easy to understand. The book is well-organized and engaging, using personal anecdotes to make the content relatable and informative.' Danielle Stepien, Doody's Reviews

• 1. Physician heal thyself; 2. Evaluating new advances in Alzheimer's research – separating hype from fact; 3. Alzheimer's dementia or Alzheimer's disease – what's the difference and why should we care?; 4. The first patient with Alzheimer's disease; 5. Kidnapped in Kinshasa; 6. Smell, disgust and Alzheimer's; 7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart; 8. Lost in the fog of Alzheimer's; 9. My father's 'stuff'; 10. Face blindness during a pandemic; 11. Biomarkers for Alzheimer's disease; 12. Olfactory impairment in Covid-19 and Alzheimer's; 13. Alzheimer's disease and work; 14. Crossword controversies; 15. Can loneliness increase risk for dementia?; 16. Excessive laxative use and dementia; 17. Dog dementia (canine cognitive dysfunction); 18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers; 19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine); 20. More about the importance of exercise; 21. Rolling on the river; 22. The MIND Diet revisited; 23. My photographs, then and now; 24. Does cataract surgery really decrease the risk of dementia?; 25. Hearing loss, aphasia and dementia; 26. To sleep, perchance to dream; 27. The amyloid hypothesis is not dead, but it may be gasping for breath; 28. Could Lecanemab offer a ray of hope?; 29. A fatal case of multiple brain hemorrhages associated with Lecanemab; 30. Cerebral amyloid angiopathy (CAA) – should it be a contraindication for drugs like Lecanemab?; 31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications; 32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease; 33. Repurposing old drugs for Alzheimer's treatment; 34. Writing while impaired; 35. Spreading the word; 36. Saying goodbye to Lizzy G; 37. Amyloid and tau PET scans of my brain; 38. Running on a field of dreams; 39. Living in the moment.

Daniel Gibbs is a retired general neurologist with mild Alzheimer's dementia. He has written previously about his experiences as seen from two points of view, doctor and patient, in A Tattoo on my Brain: A Neurologist's Personal Battle against Alzheimer's Disease, Cambridge University Press, 2021 and 2023 (revised edition).

'The book combines professional expertise with personal experience, offering unique and empathetic insights. The writing is clear and accessible, making complex medical concepts easy to understand. The book is well-organized and engaging, using personal anecdotes to make the content relatable and informative.' Danielle Stepien, Doody's Reviews

• 1. Physician heal thyself; 2. Evaluating new advances in Alzheimer's research – separating hype from fact; 3. Alzheimer's dementia or Alzheimer's disease – what's the difference and why should we care?; 4. The first patient with Alzheimer's disease; 5. Kidnapped in Kinshasa; 6. Smell, disgust and Alzheimer's; 7. Apolipoprotein-4 (APOE-4): bad for the brain and bad for the heart; 8. Lost in the fog of Alzheimer's; 9. My father's 'stuff'; 10. Face blindness during a pandemic; 11. Biomarkers for Alzheimer's disease; 12. Olfactory impairment in Covid-19 and Alzheimer's; 13. Alzheimer's disease and work; 14. Crossword controversies; 15. Can loneliness increase risk for dementia?; 16. Excessive laxative use and dementia; 17. Dog dementia (canine cognitive dysfunction); 18. The possible role of brain inflammation in Alzheimer's disease may be more significant in APOE-4 carriers; 19. Surprisingly good news about the acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine); 20. More about the importance of exercise; 21. Rolling on the river; 22. The MIND Diet revisited; 23. My photographs, then and now; 24. Does cataract surgery really decrease the risk of dementia?; 25. Hearing loss, aphasia and dementia; 26. To sleep, perchance to dream; 27. The amyloid hypothesis is not dead, but it may be gasping for breath; 28. Could Lecanemab offer a ray of hope?; 29. A fatal case of multiple brain hemorrhages associated with Lecanemab; 30. Cerebral amyloid angiopathy (CAA) – should it be a contraindication for drugs like Lecanemab?; 31. Hitting the sweet spot in the spectrum of Alzheimer's disease for future trials of anti-amyloid medications; 32. Disappointing results of two human trials of monoclonal antibodies in Parkinson's disease; 33. Repurposing old drugs for Alzheimer's treatment; 34. Writing while impaired; 35. Spreading the word; 36. Saying goodbye to Lizzy G; 37. Amyloid and tau PET scans of my brain; 38. Running on a field of dreams; 39. Living in the moment.